IPAQ Lipohypertrophy Lipoatrophy
Prevalence Ratio (95% CI)     P value Prevalence Ratio (95% CI)     P value
Men
Actives*
Insufficient physical activity

1.0
1.31 (1.07-1.60)


0.008

1.0
0.93 (0.80-1.08)


0.3
Model 1* 1.31 (1.07-1.59) 0.008 0.93 (0.80-1.07) 0.3
Model 2** 1.30 (1.07-1.59) 0.009 0.94 (0.91-1.08) 0.4
Model 3*** 1.30 (1.07-1.58) 0.01 0.94 (0.82-1.09) 0.4
Model 4**** 1.30 (1.07-1.58) 0.009 0.94 (0.82-1.09) 0.4
Model 5***** 1.34 (1.10-1.63) 0.004 0.93 (0.80-1.07) 0.3
Model 6****** 1.34 (1.10-1.63) 0.004 0.92 (0.80-1.07) 0.3
Women
Actives*
Insufficient physical activity

1.0
0.91 (0.78-1.06)


0.2
 
1.0
0.87 (0.74-1.03)


0.10
Model 1* 0.91 (0.78-1.06) 0.2 0.88 (0.75-1.03) 0.11
Model 2** 0.92 (0.79-1.08) 0.3 0.89 (0.76-1.04) 0.15
Model 3*** 0.93 (0.79-1.08) 0.3 0.89 (0.76-1.05) 0.17
Model 4**** 0.92 (0.79-1.08) 0.3 0.90 (0.76-1.06) 0.19
Model 5***** 0.93 (0.80-1.08) 0.3 0.90 (0.77-1.06) 0.2
Model 6****** 0.93 (0.80-1.08) 0.3 0.91 (0.77-1.07) 0.2
*adjusted for age
**adjusted for age and race
***adjusted for age, race and education
****adjusted for age, race, education and pack years
*****adjusted for age, race, education, binge drinking and CD4
******adjusted for age, race, education, binge drinking, CD4 and HAART
Table 3: Association between physical activity and lipohypertrophy and lipoatrophy adjusted for confounding variables.